#In Vitro Fertilization Devices Market

[healthcare-domain]

Infertility Treatment Market Scope of Current and Future, Key Players Analysis by 2026

According to the new market research report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Infertility Treatment Market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1% during the forecast period.

Browse in-depth TOC on "Infertility Treatment Market"

215 – Tables 40 – Figures 255 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43497112

The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years

The infertility treatment market include major Tier I and II suppliers of infertility treatment equipment, media & consumables are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112

COVID-19 has impacted their businesses as well. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete.

The fertility rate worldwide is declining steadily owing to various factors, such as the growing trend of late marriages and increasing age-related infertility. Global fertility rates are projected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. This declining fertility rate has led to a significant increase in the demand for infertility treatment products that determine the fertility window in males and females.

The rise in number of fertility clinics to support the market growth during the forecast period.

Significant rise in number of fertility clinics, coupled with the decline in the fertility rate across the globe. Along with this growing focus of players and government towards the launching and acquiring new fertility centers across the globe is likely to contribute towards the growth of the segment. The expansion of fertility clinics equipped with advanced technology is anticipated to increase the accessibility of infertility treatment devices among infertile couples.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=43497112

Asia Pacific likely to emerge as the fastest-growing infertility treatment market, globally

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the infertility treatment market in the region.

Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US), among others

[wellnessweb]

IVF Market Size: A Look at the Major Players

The In Vitro Fertilization (IVF) Market was valued USD 18.82 billion in 2023, anticipated to reach USD 35.83 billion by 2032 with a compound annual growth rate at 7.47% during the forecast period 2024-2032.The In Vitro Fertilization (IVF) market is witnessing unprecedented growth driven by technological advancements, rising infertility rates, and increasing societal acceptance. Innovations such as time-lapse imaging, genetic screening, and personalized IVF protocols are enhancing success rates and patient experiences. Additionally, the market is benefiting from a surge in fertility tourism, where couples seek affordable and high-quality treatment options abroad. With evolving healthcare policies, greater insurance coverage, and a growing awareness of reproductive health, the IVF market is poised for significant expansion, catering to a diverse and global clientele seeking to overcome reproductive challenges.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/1053

Market Scope & Overview

The scope, global demand, marketability, profitability, and potential of the industry are all extensively covered in the most recent market research report. The research report examines the market in depth and offers details on a variety of subjects, including market drivers, constraints, opportunities, and threats. The potential for growth at the international, regional, and industrial levels is examined by In Vitro Fertilization Market  research. The study also examines the consequences of the epidemic and offers suggestions for reducing market volatility.

The market research report presents an international viewpoint on the level of industry competition in various regions and markets throughout the world. A dashboard analysis of well-known companies is also included in the In Vitro Fertilization Market  research report, showing their successful marketing strategies, market presence, and most recent successes in both historical and contemporary contexts.

Market Segmentation Analysis

By Instrument

Disposable Devices

Culture Media

Cryopreservation Media

Embryo Culture Media

Ovum Processing Media

Sperm Processing Media

Equipment

Sperm Analyzer Systems

Imaging Systems

Ovum Aspiration Pumps

Micromanipulator Systems

Incubators

Gas Analyzers

Laser Systems

Cryosystems

Sperm Separation Devices

IVF Cabinets

Anti-vibration Tables

Witness Systems

Other

COVID-19 Impact Analysis

A comprehensive risk analysis and business ideas for the target market were created over time. The market circumstances prior to and following COVID-19 are also contrasted in this study paper. The influence of the COVID-19 epidemic on the market was thoroughly examined by the In Vitro Fertilization Market  report.

Regional Outlook

In order to obtain qualitative and quantitative market data from internal and external sources, extensive multi-level research was first done. The plan also calls for the development of projections and overviews of regional markets for each category. During the In Vitro Fertilization Market  research, the total market size was calculated using both primary and secondary data.

Competitive Analysis

Genuine information can help investors make smarter financial choices. In order to assist companies in the In Vitro Fertilization Market sector in making wiser decisions, the research's competition landscape section also includes the most recent information on recent partnerships, mergers, and acquisitions as well as key competitors' tactics.

Key Questions Answered in the In Vitro Fertilization Market  Report

What impact will COVID-19 have on your target market?

Which market considerations have recently influenced decisions the most?

What are the target market's opportunities, threats, and prospects for the future?

Conclusion

In order to provide a thorough picture of the industry and help businesses better appreciate the possibilities offered by the various regional regions, the research report examines the In Vitro Fertilization Market .

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Patient Portal Market Analysis

Plasma Therapy Market Analysis

Preeclampsia Diagnostics Market Analysis

Serum free Media Market Analysis

Glaucoma Therapeutics Market Analysis

[themarketupdate]

Biosensors Market is set for a Potential Growth Worldwide: Excellent Technology Trends with Business Analysis

Latest added Biosensors Market research study by Archive Market Research offers detailed outlook and elaborates market review till 2030. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are Bio-Rad Laboratories Inc.,Medtronic,Abbott Laboratories,Biosensors International Group, Ltd.,Pinnacle Technologies Inc.,Ercon, Inc.,DuPont Biosensor Materials,Johnson & Johnson,Koninklijke Philips N.V.,LifeScan, Inc.,QTL Biodetection LLC,Molecular Devices Corp.,Nova Biomedical,Molex LLC,TDK Corp.,Zimmer & Peacock AS,Siemens Healthcare etc.  Click for Free Sample Report + All Related Graphs & Charts https://archivemarketresearch.com/report/anti-pollution-hair-care-products-market-19/sample-report The Biosensors Market size was valued at USD 31.29 Billion in 2023 and is projected to reach USD 53.76 Billion by 2032, exhibiting a CAGR of 8.04 % during the forecasts period. The latest edition of this report you will be entitled to receive additional chapter / commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation. Each of the segment analysis table for forecast period also high % impact on growth. The Global Biosensors segments and Market Data Break Down are illuminated below: {"Technology: Electrochemical, Piezoelectric, Thermal"}

Have Any Questions Regarding Global Biosensors Market Report, Ask Our Experts@ https://archivemarketresearch.com/report/anti-pollution-hair-care-products-market-19/enquiry-before-buy This report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. Thanks for reading this article, we can also provide customized report as per company’s specific needs. You can also get separate chapter wise or region wise report versions including North America, Europe or Asia.

More Reports:

 https://archivemarketresearch.com/reports/biosensors-market-2539  https://archivemarketresearch.com/reports/in-vitro-fertilization-microscope-market-2599 Contact US : Craig Francis (PR & Marketing Manager) Archive Market Research Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[tritonmarketresearchamey]

Male Infertility Market: Asia-Pacific Size & Analysis

As per a study by WHO, approximately 17.5% of the global adult population (around 1 in 6) experience infertility. Among these, male factors are responsible for around 20-30% of all infertility cases. Over the past decade, sperm count has halved globally owing to irregular morphology, delayed sperm mortality, alcohol consumption, smoking, etc. This high prevalence has elevated the global demand for effective infertility treatments, including assisted reproductive technology (ART). As per our estimates, the global male infertility market is set to advance with a CAGR of 4.81% during the forecast period 2023-2030, garnering $5780.03 million by 2030.

Despite the stigma, infertility research has come a long way, with one aspect gaining recognition - male factor infertility. Studies, including those published by the Medical Journal of Australia in 2022, reveal that male infertility connects to cancer, early mortality, and other related medical issues. As a result, cutting-edge test types have been developed, including oxidative stress analysis, oxidative stress analysis, etc.

As male infertility continues to be a prevalent concern worldwide, breakthroughs in research have enabled better diagnosis and treatment options, especially in developing economies.

Asia-Pacific: A Forthcoming Leader in Male Infertility Treatment

From increasing disposable income to technological advancements, male infertility treatments have soared across various nations, especially South Korea, China, and India. As per our analysis, the Asia-Pacific male infertility market is estimated to advance with a CAGR of 5.38% during the forecast period 2023-2030, emerging as the fastest-growing region.

In terms of advancements, a research team at Kumamoto University introduced a cell sorter with microfluidic chip technology that minimized negative effects on cells and sperm. Another initiative includes the smartphone platform YO Home Sperm Test, introduced by Medical Electronic Systems in India. As the region continues to witness cutting-edge innovations, stakeholders can look forward to a promising landscape for male infertility treatments and services.

China leads with $258.11 million in 2022

An increased prevalence of diseases such as diabetes, genetic abnormalities, and infections like chlamydia, gonorrhea, mumps, and HIV has been observed, leading to a rise in male infertility cases. This has elevated the adoption of assisted reproductive technology (ART) , especially IVF. As of June 2021, China boasts over 529 ART-approved medical facilities and around 27 sperm banks.

In terms of treatment, ART dominated with $2299.32 million in 2022. From Intracytoplasmic Sperm Injection (ICSI) and in vitro fertilization (IVF) to cryopreservation and Preimplantation Genetic Diagnosis (PGD), ART encompasses a variety of treatments. Recent developments in ART have further expanded its capabilities and accessibility. For instance, a research team led by the University of Adelaide, in collaboration with Fertilis, launched a groundbreaking micro-device that offers a new reproductive therapy option for males with low sperm counts.

Another contributing factor includes proactive government steps to offer free fertility therapy to individuals through the National Insurance Program. The expansion of coverage by the National Healthcare Security Administration, announced in 2023, aims to provide financial assistance for couples seeking fertility treatments, including various ART methods.

South Korea Witnessing fastest growth at 8.51% of CAGR in 2023-2030

From lifestyle changes to the prevalence of diseases like diabetes and cancer, the landscape of male infertility is significantly transforming in South Korea. According to the National Center for Biotechnology Information, in 2020, a staggering 6.05 million Koreans aged 30 and older, constituting 19.2% of males, were affected by diabetes mellitus. Diabetes, a significant health issue, is increasingly impacting male fertility.

Cancer, another critical health concern, also plays a role in the rising number of male infertility cases. Estimates highlight that out of the 230,317 newly diagnosed cancer cases in Korea in 2020, a substantial 121,263 were in men. To address this growing challenge, numerous commercial companies and public institutions offer cutting-edge male infertility treatments. For instance, the CHA Fertility Centre in South Korea provides advanced treatments like semen analysis, karyotyping, and microsurgical multiple testicular sperm extraction (M-TESE) for infertile men.

The Shift from Conventional Approaches to Minimally Invasive Procedures

When it comes to surgical procedures, the focus has always been on safety and patient outcomes. In this regard, minimally invasive techniques have gained popularity in reducing postoperative patient morbidity compared to conventional approaches. In the realm of assisted reproductive technology, these advancements have paved the way for a range of procedures, from intrauterine insemination (IUI) to cutting-edge intracytoplasmic sperm injection (ICSI).

While these treatments have gained momentum, medical micro-robotics is another notable technology on the horizon. Controlled by external physical fields like magnetism or ultrasound, these microrobots can perform various tasks, making them more than passive carriers. Hence, advancements in minimally invasive procedures are expected to lower infertility treatment costs, further opening avenues for the male infertility treatment market.

 

FAQs:

Q1) Which are the key test types in the male infertility market?

DNA fragmentation technique, oxidative stress analysis, sperm agglutination, computer-assisted semen analysis, and microscopic examination are among the key male infertility test types.

Q2) Which countries are considered in the Asia-Pacific male infertility market?

China, Japan, India, South Korea, ASEAN Countries, and Australia & New Zealand are considered in the regional market.

[delveinsight12]

Navigating the Landscape of the Female Infertility Market: Causes, Treatments, and Market Dynamics

Female infertility is a complex and widespread medical concern that affects millions of women globally. This condition, defined by the inability to conceive after a year of regular unprotected intercourse, can be attributed to various factors. The female infertility market has witnessed significant advancements in recent years, with pharmaceutical companies actively engaged in research and development to address the diverse causes of infertility.

Female infertility Causes and Symptoms

Understanding the causes of female infertility is crucial for developing effective treatment strategies. Common causes include:

Ovulatory Disorders: Irregular or absent ovulation is a leading cause of female infertility. Conditions like polycystic ovary syndrome (PCOS) and primary ovarian insufficiency can disrupt the normal ovulatory process.

Tubal Factors: Blocked or damaged fallopian tubes can impede the passage of eggs, preventing fertilization.

Uterine Factors: Structural abnormalities or conditions such as endometriosis can affect the uterus, making implantation difficult.

Age-related Decline in Fertility: Advanced maternal age is associated with a decline in egg quality and quantity, affecting fertility.

Symptoms of female infertility may not be apparent, making it essential for couples experiencing difficulty conceiving to seek medical evaluation.

Female infertility Treatment Algorithms

The treatment of female infertility often involves a stepwise approach tailored to the underlying causes. Key components of the treatment algorithm include:

Ovulation Induction: Fertility drugs such as clomiphene citrate or gonadotropins may be prescribed to stimulate ovulation.

Assisted Reproductive Technologies (ART): In vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and other ART procedures are commonly used to overcome various fertility issues.

Surgery: Surgical interventions may be necessary to address structural abnormalities in the reproductive organs.

Key Female infertility Companies

Several pharmaceutical companies are actively contributing to the development of therapies to address female infertility. Key players in the market include:

Merck & Co., Inc.: Known for its involvement in reproductive health, Merck offers fertility drugs such as Gonal-f for ovulation induction.

Ferring Pharmaceuticals: Ferring is a prominent player in reproductive medicine, providing medications like Menopur for fertility treatment.

Pfizer Inc.: Pfizer's portfolio includes medications that may be used in fertility treatments, contributing to the management of female infertility.

Cook Medical: Cook Medical focuses on innovative medical solutions, including medical devices used in assisted reproductive technologies.

Female infertility Epidemiology

Female infertility affects a substantial number of couples globally. According to epidemiological studies, the prevalence of infertility varies across regions, with age being a significant factor. The increasing trend of delaying childbirth and lifestyle factors contribute to the rising incidence of female infertility.

Request for a sample report @ Female Infertility Market Trends

About DelveInsight

DelveInsight is a premier market research and consulting firm that provides comprehensive insights into the healthcare sector, including the female infertility market. Its reports encompass market trends, competitive landscape analysis, and emerging opportunities. By leveraging DelveInsight's expertise, pharmaceutical companies, investors, and other stakeholders can make informed decisions to navigate the dynamic landscape of female infertility.

In conclusion, the female infertility market is evolving rapidly, driven by advancements in reproductive medicine and the dedication of pharmaceutical companies to address the diverse causes of infertility. Understanding the complexities of the market, coupled with insights from DelveInsight's reports, empowers decision-makers to contribute to improved outcomes for couples facing challenges in achieving parenthood. DelveInsight's reports serve as valuable resources for strategic planning, investment, and staying abreast of the latest developments in the female infertility market.

[straitsresearchreports]

In Vitro Fertilization (IVF) Market Strategies: Navigating Challenges for Success till 2031

Industry Overview of In Vitro Fertilization (IVF) Market

Straits Research has added a new report titled, “Global In Vitro Fertilization (IVF) Market Market Professional Report 2031” to its vast repository of research reports. This is a comprehensive report focused on the current and prospects of the Global In Vitro Fertilization (IVF) Market Market. The report also mentions the impact of the coronavirus pandemic on the market. Furthermore, the study includes the steps the leading industry players have taken to recover the losses (if any).

The global In vitro fertilization (IVF) market size is growing at a CAGR of 6.2% during the forecast period (2023–2031).

The report on the Global In Vitro Fertilization (IVF) Market Market offers data from previous years along with an in-depth analysis from 2023 to 2031 based on revenue (USD Billion). Besides, the report offers a comprehensive analysis of the factors driving and restraining the growth of the market coupled with the impact they have on the demand over the forecast period.

Request Sample Report of Global In Vitro Fertilization (IVF) Market Market @ https://straitsresearch.com/report/in-vitro-fertilization-market/request-sample

OvaScience

EMD Serono Inc.

Vitrolife AB

Irvine Scientific

Cook Medical Inc.

Cooper Surgical Inc.

Genea Biomedx

Thermo Fisher Scientific Inc.

Progyny, Inc.

Boston IVF

The market is segmented into different sections such as: by product type, by technology type, by application, by end-users, by deployment mode, and by key geography. The report then employs market breakdown and data triangulation procedures to complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments. The report on the Global In Vitro Fertilization (IVF) Market Market has been curated by analyzing the top players functioning in the market. In order to get an in-depth analysis of the market, the report carried out a SWOT analysis, Porter’s five forces analysis, and Pestel analysis.

Market Segmentation:

By Type, Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor

By End-use, Fertility Clinics, Hospitals

By Instrument, Culture Media, Disposable Devices, Capital Equipment

This report forecasts revenue growth at the global, regional, and local levels and provides an analysis of the most recent industry trends from 2023 to 2031 in each of the segments and sub-segments. In addition, the report highlights the impact of COVID-19 on the Global In Vitro Fertilization (IVF) Market Market and how the market is undertaking measures to reduce the losses. Some of the major geographies included in the market are given below:

North America(S., Canada)

Europe(K., Germany, France, Italy)

Asia Pacific(China, India, Japan, Singapore, Malaysia)

Latin America(Brazil, Mexico)

Middle East & Africa

Buy Now: https://straitsresearch.com/buy-now/in-vitro-fertilization-market

Key Questions Answered in the Report:

What is the current scenario of the Global In Vitro Fertilization (IVF) Market Market?

How is the market going to prosper throughout the next 6 years?

What are the emerging technologies that are going to profit the market?

What are the historical and current sizes of the Global In Vitro Fertilization (IVF) Market Market?

Which segments are the fastest growing and the largest in the market? What is their market potential?

What are the driving factors contributing to the market growth during the short, medium, and long term? What are the major challenges and shortcomings that the market is likely to face? How can the market solve the challenges?

What are the major strategies adopted by the leading players to expand their market shares?

Latest Updated Reports

https://justpaste.it/wine-industry

Contact Us

Email: sales@straitsresearch.com Address: 825 3rd Avenue, New York, NY, USA, 10022 Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)

About Straits Research

Straits Research is dedicated to providing businesses with the highest quality market research services. With a team of experienced researchers and analysts, we strive to deliver insightful and actionable data that helps our clients make informed decisions about their industry and market. Our customized approach allows us to tailor our research to each client's specific needs and goals, ensuring that they receive the most relevant and valuable insights.

[infinitiresearch]

In Vitro Fertilization (IVF) Devices Market| Market Size, Share, Trends, Analysis, Growth and Forecast, 2024 – 2028

Originally published on Technavio: In Vitro Fertilization (IVF) Devices Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, France, China - Size and Forecast 2024-2028

The in vitro fertilization (IVF) devices market plays a pivotal role in assisting couples facing infertility issues to achieve pregnancy. IVF has become a widely accepted and effective assisted reproductive technology, and the demand for associated devices has surged with the increasing prevalence of infertility and a growing global awareness of fertility treatments. This market encompasses a range of devices and instruments essential for various stages of the IVF process, including sperm preparation, egg retrieval, fertilization, and embryo transfer.

One of the primary drivers of the IVF devices market is the rising incidence of infertility worldwide. Factors such as delayed childbearing, lifestyle changes, and underlying health conditions contribute to infertility challenges for many couples. IVF procedures offer a viable solution, and the associated devices are critical in ensuring the success and efficiency of these fertility treatments. The market responds to the increasing demand for advanced and innovative devices that enhance the success rates of IVF procedures.

Technological advancements have significantly impacted the IVF devices market, leading to the development of more sophisticated and precise instruments. Innovations such as time-lapse imaging systems for monitoring embryo development, advanced cryopreservation techniques, and automated sperm analyzers contribute to the improvement of success rates and the overall patient experience in IVF procedures. These technologies enhance the precision and control that healthcare professionals have throughout the IVF process.

The IVF devices market is also influenced by regulatory frameworks and ethical considerations associated with assisted reproductive technologies. Stricter regulations and guidelines govern the manufacturing and use of IVF devices to ensure patient safety and the ethical handling of reproductive materials. Manufacturers in this market must adhere to stringent quality standards, contributing to the overall reliability and safety of IVF procedures.

The impact of the COVID-19 pandemic on the IVF devices market has been multifaceted. While the initial phase saw disruptions due to lockdowns and restrictions on elective medical procedures, the importance of family planning and the resilient demand for fertility treatments led to a rebound in the market. The pandemic underscored the significance of reproductive health, driving the adoption of innovative technologies to address challenges posed by the global health crisis.

To Learn deeper into this report , View Sample PDF

Looking ahead, the IVF devices market is expected to witness continued growth as infertility remains a prevalent issue and as societal trends contribute to delayed family planning. Ongoing research and development in reproductive medicine will likely lead to further innovations in IVF devices, with a focus on improving success rates, reducing procedural invasiveness, and addressing ethical considerations. As the field of assisted reproductive technologies evolves, the IVF devices market will play a crucial role in providing effective solutions for individuals and couples seeking to build their families.

For more information please contact.

[desaletushki]

In Vitro Fertilization Market Size, Share & Trends Analysis Report 2030

The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.72% from 2023 to 2030. The market is driven by the continuous efforts of the market players, government initiatives to make available better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. The expansion of fertility procedures such as ICSI for treating infertility is expected to positively impact market growth in the near future.

Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during In Vitro Fertilization (IVF) is further expected to drive the IVF market. The insurance providers are providing coverage for IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) is a result of factors such as a behavioral shift in society. These factors include a shift from rural to urban societies, the increased age of the first birth, postponement of marriage, an increasing number of women employees, and lower marriage rates. In March 2020, in-person fertility treatments in U.S. and Canada were suspended due to COVID-19 by the American Society of Reproductive Medicine and Canadian Fertility and Andrology Society. However, treatment is resuming in many countries with the ease of COVID-19 restrictions. The research findings published by the Obstetrics and Gynecology journal, in January 2022 reported COVID-19 vaccines won't harm IVF outcomes. This is expected to prove significant in promoting the uptake of IVF in eligible vaccinated individuals.

Request a free sample copy or view the report summary: https://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market 

In Vitro Fertilization Market Report Highlights

The culture media segment dominated the market in terms of revenue in 2022. A number of research activities are being undertaken to improve the efficiency of cultural media. For instance, Vitrolife showcased its research on SpermFreeze solution at the American Society for Reproductive Medicine (ASRM) that established the effectiveness of its solution for sperm recovery and sperm-hyaluronic acid-binding

Europe dominated the market for procedures and instruments in 2022. Adoption of advanced technologies such as time-lapse microscopy by the clinics, availability of affordable treatment, and adherence to medical standards contribute to its market dominance

In APAC, the market is expected to witness increased demand for IVF owing to fertility tourism and the availability of funding for the treatment. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle

The developing countries in the Asia Pacific region are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill for the regulation of clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy

In January 2020, Merck received Marketing Authorization (MA) from the European Commission (EC) for its recombinant human follicle-stimulating hormone, GONAL-f (follitropin alfa) 150 IU pen

In Vitro Fertilization Market Segmentation 

Grand View Research has segmented the global in vitro fertilization market based on instrument, procedure type, end-use, and region:

In Vitro Fertilization Instrument Outlook (Revenue, USD Million, 2017 - 2030)

Disposable Devices

Culture Media

Capital Equipment

In Vitro Fertilization Procedure Type Outlook (Revenue, USD Million, 2017 - 2030)

Fresh Donor

Frozen Donor

Fresh Non-donor

Frozen Non-donor

In Vitro Fertilization End-use Outlook (Revenue, USD Million, 2017 - 2030)

Fertility Clinics

Hospitals & Other Settings

Regional Insights

Europe dominated the in vitro fertilization market and accounted for the largest revenue share of more than 36.98% in 2022. Factors, such as rising medical tourism and legal revisions related to IVF techniques, will propel the regional market growth during the forecast years. An increasing number of people from the U.S. are traveling to the Czech Republic to avail of IVF treatments at lower costs. As per an ESHRE fact sheet, in January 2017, some reimbursement is available for ART in almost all EU member states (except Lithuania and Ireland). In Asia Pacific, the market for IVF is estimated to register the fastest CAGR of 7.29% from 2023 to 2030.

The demand for IVF treatment is expected to boom in the Asia Pacific region due to fertility tourism, increasing foreign investment to penetrate economically developing countries, and the changing regulatory landscape. Incidence of infertility has increased due to changes in lifestyles, such as the increased prevalence of obesity and stress, lack of exercise, improper eating habits, lack of nutrition, and rise in pollution, as well as due to prevalence of medical conditions such as diabetes. North America is also expected to witness increasing demand for fertility treatment in the coming years. Standardization of procedures through automation, regulatory reforms, government funding for egg/sperm storage, and the introduction of more IVF treatments by industry players are among the major factors contributing to the growth of the IVF market in North America.

List of Key Players in In Vitro Fertilization Market

OvaScience

EMD Serono Inc.

Vitrolife AB

Irvine Scientific

Cook Medical Inc.

Cooper Surgical Inc.

GeneaBiomedx

Thermo Fisher Scientific Inc.

Progyny, Inc.

Boston IVF

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/in-vitro-fertilization-market 

[market-insider]

Future of Veterinary Artificial Insemination: Market Forecast and Growth Opportunities

Veterinary Artificial Insemination (AI) is a reproductive technique that involves the insertion of semen into the reproductive tract of female animals to achieve fertilization. AI is commonly used in the livestock industry, where it enables breeders to improve the genetics of their herds by using semen from superior sires. The process involves collecting semen from a male animal and depositing it into the female's reproductive tract using a specialized device. AI is a safe and effective way of improving breeding outcomes and can be used to overcome infertility or breeding issues. It also helps to prevent the spread of diseases that can be transmitted through natural breeding. Veterinary AI is an important tool for animal breeders and is widely used in many parts of the world.

Gain deeper insights on the market and receive your free copy with TOC now @: Veterinary Artificial Insemination Market Report

There have been several recent developments that have improved the effectiveness and efficiency of the technique. One major development is the use of sex-sorted semen, which allows breeders to choose the gender of the offspring they produce. This technology is particularly useful in dairy and beef production, where certain genders may be more desirable for specific purposes. Another development is the use of advanced reproductive technologies such as in vitro fertilization (IVF) and embryo transfer (ET), which can be combined with AI to increase breeding success rates. Additionally, there have been advancements in AI equipment and techniques, such as the use of electronic identification and automatic semen dispensers, which have streamlined the AI process and reduced labor costs. Overall, these developments have made Veterinary AI a more powerful tool for animal breeders and improved the efficiency and accuracy of the breeding process.

The global veterinary artificial insemination market size is anticipated to reach USD 7.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 6.5% from 2022 to 2030. The key factors driving the market growth include increasing consumption of animal protein, growing demand for livestock productivity, and adoption of sexed semen. In September 2021, LIC- an agritech co-operative based in New Zealand launched a sexed semen lab in the country to meet the growing demand.

[healthcare-domain]

Infertility Treatment Market Size, Share | 2026 | MarketsandMarkets

According to the new market research report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Infertility Treatment Market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1% during the forecast period.

The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years

The infertility treatment market include major Tier I and II suppliers of infertility treatment equipment, media & consumables are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112

COVID-19 has impacted their businesses as well. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete. In India, 30 lakh people seek infertility treatment every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.

The rise in number of fertility clinics to support the market growth during the forecast period.

Significant rise in number of fertility clinics, coupled with the decline in the fertility rate across the globe. Along with this growing focus of players and government towards the launching and acquiring new fertility centers across the globe is likely to contribute towards the growth of the segment. The expansion of fertility clinics equipped with advanced technology is anticipated to increase the accessibility of infertility treatment devices among infertile couples.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=43497112

Asia Pacific likely to emerge as the fastest-growing infertility treatment market, globally

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the infertility treatment market in the region.

Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US).

[reportstores]

Demand for Fertility-Related Devices Expected to Rise

Numerous nations in the North American, European, and Asia-Pacific regions are seeing an increase in the use of ART/IUI as the problem of infertility becomes more prevalent.

In spite of a global decline in fertility, an estimated 8–12% of couples worldwide experience infertility. Global factors that contribute to low fertility There are a number of factors that are thought to contribute to low fertility rates, one of which is an increase in the mother's age at first birth. To put it simply, many women are opting to delay having children. Female fertility begins to decline between the ages of 25 and 30, which can increase the number of women who have difficulty conceiving.

Calorie restriction, excessive exercise, smoking, obesity, and stress are additional risk factors for infertility.

Premature ovarian insufficiency, polycystic ovary syndrome, endometriosis, testicular deficiency, and post-testicular impairment in men, as well as specific diseases like Chlamydia Trachomatis Infections Drugs Development Market are thought to affect fertility.

Treatment options for infertility There are now a lot of different treatment options for people who are having trouble having children. Artificial insemination methods like intrauterine insemination (IUI) and assisted reproductive technology (ART) methods like in vitro fertilization and intracytoplasmic sperm injection are examples of these.

Numerous nations in the North American, European, and Asia-Pacific regions are seeing an increase in the use of ART/IUI as the problem of infertility becomes more prevalent. Despite the high cost of ART/IUI procedures, many nations provide full or partial coverage for these procedures through their national health plans.

Legal requirements and financial assistance Unfortunately, these reimbursement policies frequently do not always apply to same-sex couples or single women. In addition, laws governing medically assisted reproduction procedures may differ significantly from nation to nation. Gamete donation and/or surrogacy are also prohibited in some nations, and certain patient groups may not always have access to ART/IUI.

Numerous individuals have traveled abroad for fertility treatment due to these and other issues, such as lengthy waiting lists and costs. In nations with more liberal government policies, this "medical tourism" helps to strengthen the reproductive healthcare industry.

Medical devices It is anticipated that the percentage of patients seeking medical assistance for infertility will rise over the next ten years. This is because people are more aware of the disease, there are more treatment options and they are easier to get, and people are less afraid of ART/IUI technologies.

Sales of associated devices like reproductive hormones and proteins tests, which are utilized both for the diagnosis of infertility and for guiding patient treatment, are anticipated to be driven by increases in ART/IUI utilization. This is in addition to the devices that are associated with the procedures themselves.

[esglatestmarketnews]

In-vitro Fertilization Microscopes Market Growth Prospects And Industry Growth Rate 2022-2030

The rising prevalence of infertility among men and women is expected to foster the growth of the market for IVF microscopes during the forecast period.

The global in-vitro fertilization microscopes market size is expected to reach USD 193.2 million by 2030, according to a new report by Grand View Research. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. The market has witnessed advancements in microscopes and microscope-related equipment for use in in-vitro fertilization. Artificial Intelligence (AI), embryo assessment, and sperm selection are some of the applications targeted for innovation.

Manufacturers are providing upright microscopes, digital microscope cameras, and software to view images together as a sperm analysis system to provide the complete solution for semen analysis. Moreover, as sperm analysis can be better studied by maintaining a certain temperature of the sample, manufacturers are coupling the use of such devices along with an upright microscope. For instance, PROiSER provides ISAS HEAT, a slide warmer, compatible with its UB200i upright microscope used along with Computer Assisted Semen Analysis (CASA) systems.

The demand for In-vitro Fertilization (IVF) procedures is now increasing due to the relaxation of travel restrictions and supporting government guidelines. For instance, the American Society of Reproductive Medicine (ASRM) announced that there is a need to ensure reproductive care with maximal safety as we will have to continue to live with a COVID-19.

In-vitro Fertilization Microscopes Market Report Highlights

• Based on the end-use, the clinical segment dominated the market in 2021 in terms of revenue. IVF clinics provide a range of services, including healthy oocyte identification, semen analysis, ICSI, embryo monitoring, and freezing and storage of embryos

• The clinical segment is also expected to witness the fastest growth from 2022 to 2030 due to the increasing adoption of IVF treatment. Moreover, manufacturers are developing innovative products with integrated technologies, such as Artificial Intelligence (AI)

• Europe held the largest share in terms of revenue in 2021 due to factors such as the high cost of IVF treatment and the availability of reimbursement. The Asia Pacific region is expected to witness the fastest growth from 2022 to 2030 due to the initiatives to create awareness regarding IVF treatment in countries such as India

• The IVF microscopes market is saturated with many prominent players. The companies operating in the market are adopting various strategies such as product innovation, market expansion, and introduction of advanced technology to stay competitive in the market

• For instance, in February 2019, Opto GmbH debuted the DualStation embryo imaging microscope. The DualStation is designed to provide all the optical techniques and imaging requirements used by IVF processes into a single enclosed embryo chamber

The global life science microscopes industry generated over USD 3.36 billion in 2021 and is expected to grow at a CAGR of 8.9% over the forecast period. 

In-vitro Fertilization Microscopes Market Segmentation

Grand View Research has segmented the global in-vitro fertilization microscopes market on the basis of end-use and region:

In-vitro Fertilization Microscopes End-use Outlook (Revenue, USD Million, 2017 – 2030)

• Clinical

• Academic Research

In-vitro Fertilization Microscopes Regional Outlook (Revenue, USD Million, 2017 – 2030)

• North America

    o U.S.

   o Canada

• Europe

   o Germany

   o U.K.

   o France

   o Italy

   o Spain

• Asia Pacific

   o Japan

   o China

   o India

• Latin America

   o Brazil

   o Mexico

• Middle East & Africa (MEA)

   o South Africa

List of Key Players in the In-vitro Fertilization Microscopes Market

• Linkam Scientific Instruments

• Olympus Corporation

• Leica Microsystems

• Meiji Techno

• Zeiss

• Euromex Microscopen B.V.

• Labomed Europe B.V.

• Nikon Corporation

• Narishige Group

• Eppendorf AG

• Hamilton Thorne Ltd.

• Sutter Instrument Company

• Tritech Research, Inc.

Request free sample copy of Life Science Microscopes Industry Data Book @ https://www.grandviewresearch.com/sector-report/life-science-microscopes-industry-data-book/request/rs